Martin Schiller

Executive Director, Nevada Institute of Personalized Medicine
Professor of Life Sciences
Expertise: AIDS/HIV, Alzheimer's disease, Genetics, Bioinformatics, CRISPR gene editing

Biography

Martin Schiller's work is focused on short functional peptides, bioinformatics, and HIV. Schiller’s research has resulted in 60 publications supported mostly by 12 research grants from the National Institutes of Health.

He has received a number of awards, produced a suite of bioinformatics tools, and is involved in commercialization of some of his research projects. He is now the executive director of the Nevada Institute of Personalized Medicine.

Search For Other Experts On

biologyscience & technology

Martin Schiller In The News

Las Vegas Review Journal
When Martin Schiller decided to launch his own company based off the research he did at UNLV, he picked Las Vegas despite the prospect of being one of only a handful of biotechnology firms in the valley.
Vegas Inc
Contrary to what many people think, there are only about 2,000 medicines approved by the Federal Drug Administration for people. And a quarter of those are biological products, or “biologics,” including vaccines, gene therapy, tissues and similar medicines—like insulin, for example.
The New York Times
Chastened by a series of economic downturns that punished the hospitality industry, state leaders are working to broaden the economy.
Giddy
Your genes govern appearance and blood type, but they're also responsible for a whole lot more.

Articles Featuring Martin Schiller

dna strand made of veggies atop a dinner plate with silverware at sides
Business and Community | January 16, 2019

Food Genes and Me is a site and software that lets users figure out health risks and how to solve them within minutes.

World AIDS Day ribbon
Campus News | December 3, 2015

From law to health to advocacy to science, UNLV professors tackle HIV prevention, education and treatment both domestically and abroad.